Skip to main navigation Skip to search Skip to main content

A Phase II, Open-label Trial to Evaluate the Safety, Tolerability and Antiviral Activity of TMC125 in Antiretroviral Experienced HIV-1 Infected Children and Adolescents

Project: Research

Project Details

StatusFinished
Effective start/end date10/31/08 → 07/8/11

Funding

  • Tibotec Pharmaceuticals Limited: $2,864.00